Picture of Valbiotis SA logo

ALVAL — Valbiotis SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Valbiotis confirms efficacy of Lipidrive in three models and finalizes recruitment for phase I/II

Oct 16 (Reuters) - VALBIOTIS SAS  ALVAL.PA : 
    * LIPIDRIVE: EFFICACY CONFIRMED IN THREE MODELS, 
FINALIZATION OF RECRUITMENT FOR PHASE I/II IN HUMANS 
    * IN PROCESS OF RECRUITING 20 OBESE MALE VOLUNTEERS FOR 
STUDY, 18 OF WHICH HAVE ALREADY BEEN INCLUDED 
 
Source text for Eikon:  ID:nBw3mL7ra  
Further company coverage:  ALVAL.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Valbiotis SA

See all news